seventeen cents by end of october, page-10

tide can only be held for a short while • COMPLETION of several Australian safety trials for the advanced poultry product, the Poultry Productivity Enhancer. This product, under worldwide sublicense to Merial continues to progress toward commercial release.

• SUCCESSFUL laboratory construction of :> Two new Avian Influenza (Bird Flu) vaccine candidates for:- Broiler bird market- Breeder bird and Egg Layer bird markets> Coccidiosis vaccines constructed for Abic Biological Laboratories, the veterinary products division of Teva Pharmaceutical Industries Ltd These vaccine candidates are all fully laboratory tested and have passed through all quality controls – now progressing to animal trials.

• SUCCESSFUL resolution of the Pig Patent Interference in the US resulting in a stronger IP position and improved financial terms.

• NEW PATENT for pig vaccine vector filed to further strengthen and expand commercial potential.

• GRANTING of the European patent for Imugene’s poultry platform technology. Poultry patents now granted in US and Europe - the world’s major commercial poultry producing regions.

• SIGNIFICANTLY INCREASED rate of scientific progress at Imugene’s newly established research laboratory at La Trobe University.